Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $324.8900 (0.32%) ($320.6000 - $326.1595) on Mon. Feb. 26, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.1% (three month average) | | RSI | 47 | | Latest Price | $324.8900(0.32%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | | Weekly Trend | REGN declines -1.9% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -1.05% in a week (0% probabilities).
UUP(-10%) VIXM(-6%) TLT(-6%) TIP(-1%) SHY(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.05% (StdDev 2.1%) | | Hourly BBV | 0 () | | Intraday Trend | 0.2% | | | | | |
|
| Resistance Level | $336.82 | | 5 Day Moving Average | $321.02(1.21%) | | 10 Day Moving Average | $326.51(-0.5%) | | 20 Day Moving Average | $336.82(-3.54%) | | To recent high | -17.5% | | To recent low | 2.9% | | Market Cap | $34.448b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |